Research
Next Entries »Cholesterol Lowering Drugs are Worthless in Most Cases – Part Three
Monday, February 25th, 2008Before I get into today’s discussion on inflammation, please go to this link put up by Chance News, a group dedicated to reviewing information about the use of statistics in the news. They review the cholesterol news and and the statistics behind it. Go down halfway down the page to see the report. Inflammation. That is the […]
What is the FDA Thinking?
Sunday, February 24th, 2008The drug Avastin, has just been approved by the Federal Drug Administration for the treatment of breast cancer despite it having shown no benefits over exisiting drugs in prolonging life or improving the quality of life of women taking the drug. What is the point of taking a drug that doesn’t benefit the patient aside […]
Cholesterol Lowering Drugs are Worthless in Most Cases – Part Two
Monday, February 18th, 2008In one of my blogs last week, I talked about the issues with Lipitor® and the lack of the association between high cholesterol and coronary heart disease. Now let’s talk about real problems that come up by taking this drug. Say the side-effect rate is 3-5% (which is the pharmaceutical industry line) which means that given […]
Cholesterol Lowering Drugs are Worthless in Most Cases – Part One
Friday, February 15th, 2008While walking through the SeaTac Airport a few weeks ago, I saw an article in Business Week magazine that made me smile as it was saying what I have been saying for years, which is, statin drugs really don’t prevent heart disease. Aside from the Vytorin®/Zetia® debacle, the whole idea of lowering cholesterol (LDL especially) […]
Next Entries »